Celecoxib as an adjuvant to chemotherapy for patients with metastatic colorectal cancer: A randomized controlled clinical study

OBJECTIVES: To investigate the anti-tumor activity and tolerability of celecoxib as an adjuvant therapy for patients with metastatic colorectal cancer (CRC). METHODS: In this randomized controlled study, 54 patients with metastatic CRC were randomized into 2 groups; the control group (n=28) which re...

Descripción completa

Detalles Bibliográficos
Autores principales: Mostafa, Tarek M., Alm El-Din, Mohamed A., Rashdan, Amira R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Saudi Medical Journal 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280566/
https://www.ncbi.nlm.nih.gov/pubmed/35022282
http://dx.doi.org/10.15537/smj.2022.43.1.20210574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280566/
https://www.ncbi.nlm.nih.gov/pubmed/35022282
http://dx.doi.org/10.15537/smj.2022.43.1.20210574

Ejemplares similares